BIT Capital’s Tectonic Therapeutic TECX Stock Holding History

BIT Capital’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,000	Closed	-$626K	–	130
2025 Q4	$626K	Buy	+30,000	New	+$557K	0.02%	85

Other funds holding TECX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

BIT Capital's TECX Position: Q1 2026 in Review

BIT Capital sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 30,000 shares — an estimated $626K sold.

BIT Capital first reported a position in TECX in Q4 2025 and held it in 1 quarter. The position peaked at $626K in Q4 2025. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

BIT Capital reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
BIT Capital sold 30,000 Tectonic Therapeutic shares in Q1 2026, an estimated $626K.
BIT Capital first reported a position in Tectonic Therapeutic in Q4 2025 and held it in 1 quarter.
BIT Capital's Tectonic Therapeutic position peaked at $626K in Q4 2025.
111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on BIT Capital's 13F filing for Q1 2026, filed 13 May 2026.